Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | decreased ceruloplasmin level | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | increased circulating alanine transaminase level | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | increased circulating aspartate transaminase level | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | increased circulating bilirubin level | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | increased liver copper level | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | jaundice | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | oxidative stress | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | premature death | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | weight loss | | IAGP | controlled copper content diet | 25823141; 25823141; 25823141 | compared to LEA/Hok | RGD | | |